Biogen Inc. buy Truist Financial Co.
Start price
13.02.25
/
50%
€127.25
Target price
13.02.26
€202.02
Performance (%)
16.39%
Price
19:01
€148.10
Summary
This prediction is currently active. The prediction currently has a performance of 16.39%. This prediction currently runs until 13.02.26. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Biogen Inc. | -4.751% | -4.751% |
| iShares Core DAX® | 0.734% | 1.458% |
| iShares Nasdaq 100 | -2.686% | -0.146% |
| iShares Nikkei 225® | -2.261% | -2.729% |
| iShares S&P 500 | -1.346% | 0.467% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its price target lowered by analysts at Truist Financial Co. from $220.00 to $210.00. They now have a "buy" rating on the stock.
Ratings data for BIIB provided by MarketBeat